NCT07230795
AI-informed Colorectal Cancer (CRC) Screening Navigation vs. Standard of Care Among Screening-naive Penn Medicine Patients 45-49 Years Old to Increase CRC Screening Uptake
Enrolling by Invitation
NAAges 45–49InterventionalAbramson Cancer Center at Penn MedicineInvestigator-initiated
~7,120 participants
Updated 2025-11-17 on ClinicalTrials.gov
What's tested:Intervention Arm
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Enrollment in the Navigator program
Measured over 12 month
+2 more outcomes measured
Conditions
Where it's being run
1 sites across 1 statesPennsylvania1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Enrollment in the Navigator program12 month
The patient navigation will assist in completing their colorectal cancer screening. The only test are either a fecal immunochemical test (FIT) or a colonoscopy. No other tests are required.
- Completion of colonoscopy or FIT testing12 month
The patient navigation will assist in completing either a fecal immunochemical test (FIT) or a colonoscopy. The only test are either a fecal immunochemical test (FIT) or a colonoscopy. No other tests are required.
- Abnormal screening findings (positive FIT, abnormal colonoscopy findings). S12 month
We will evaluate the effectiveness of the program on uptake of navigation and completion of CRC screening, rates of abnormal screening results, abnormal stool test follow-up with diagnostic colonoscopy, time to screening uptake, and CRC and precancerous lesion detection.